Technology | March 27, 2012

FDA Clears GE Healthcare’s New Class of Angiography Systems

Class offers fixed system image quality and features with versatility of a mobile C-arm

The GE Healthcare Discovery IGS 730 angiography imaging system.

March 26, 2012 – GE Healthcare unveiled two recently U.S. Food and Drug Administration (FDA)-cleared angiography systems offering mobility and advanced imaging for interventional cardiology at the American College of Cardiology's (ACC) 61st Annual Scientific Session in Chicago this week. 

Specifically, GE highlighted its recently FDA-cleared Discovery IGS 730 system, the first interventional X-ray system designed to capture the advantages of both floor- and ceiling-mounted systems, and the mobility of a mobile C-arm. Initially introduced last fall during RSNA 2011, the Discovery system was designed to address the trade-off departments have historically needed to make between ceiling- and floor-mounted systems, eliminating the need to compromise on patient access and image quality. This laser-guided, motorized mobile gantry allows complete access to the patient and unlimited parking capability, while creating sterility for a flexible operating room (OR) environment. The unique gantry comes with a new wide bore design, which allows for steep angles, ease in 3-D acquisition, especially for large patients. 

GE will also introduce the FDA-approved Innova IGS 520/530 with the OR option to expand the use of its Innova imaging system in the hybrid OR setting. With specifically designed table and accessories, the Innova IGS 520/530 OR enables both transcatheter and open surgical procedures in one room.

GE also highlighted its Innova HeartVision solution to help support planning and guidance of structural heart procedures, especially trans-aortic valve replacement (TAVR) procedures. The HeartVision function fuses real time 2-D X-ray images and 3-D models, such as the 3-D cardiac model, from multiple modalities. It can be synchronized with electrocardiogram (ECG) gating and can help compensate for patient heart and respiratory motion throughout the procedure for quality treatment. Innova HeartVision can reduce procedure time and dose, and increase physician confidence by providing the visual tools to make challenging interventions more accessible.

“Interventional cardiology procedures are becoming increasingly complex, and now may be performed in a variety of settings in the hospital, including the operating room. GE Healthcare is revolutionizing cardiac imaging with solutions that adapt to a wider array of environments,” said Reaz Rasul, general manager, interventional cardiology, GE Healthcare - detection and guidance solutions. “With the development of Discovery IGS 730 and Innova IGS 520/530 OR, we are arming physicians with solutions that combine cutting-edge imaging with greater versatility to meet more clinical needs.”

To see a video of the system in operation when it was first unveiled at RSNA 2011, click here.

For more information: www.gehealthcare.com

Related Content

Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab| October 18, 2017
Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at...
Societies Issue New Performance and Quality Measures for Treating Patients with Heart Attack
News | Cath Lab| October 17, 2017
The American College of Cardiology and the American Heart Association recently released updated clinical performance...
First Patient Enrolled in U.S. Arm of ALIVE Pivotal Heart Failure Trial
News | Heart Failure| October 17, 2017
October 17, 2017 — BioVentrix Inc. recently announced enrollment of the first patient in the U.S.
Appropriate Use Criteria Published for Valvular Heart Disease Imaging Tests
News | Clinical Decision Support| October 16, 2017
The American College of Cardiology (ACC), along with several partnering societies, recently released appropriate use...
Dee Dee Wang runs Henry Ford Hospital's 3D printing lab for its complex structural heart cardiology program.

Dee Dee Wang, M.D., runs Henry Ford Hospital's 3-D printing lab that supports its complex structural heart program.

Feature | 3-D Printing| October 13, 2017 | Dave Fornell
Three-dimensional (3-D) printed anatomic models created from a patient’s computed tomography (CT), magnetic resonance...
Low Mortality and Stroke Risks Displayed for Minimally Invasive Aortic Valve Replacements
News | Heart Valve Technology| October 11, 2017
An analysis of more than 1,000 minimally invasive aortic valve replacements and more than 400 additional associated...
Videos | Chronic Total Occlusion (CTO)| October 09, 2017
Bill Lombardi, M.D., director of complex coronary artery interventions at the University of Washington, discusses the
BTG Acquires Roxwood Medical
News | Business| October 05, 2017
BTG plc announced it has acquired Roxwood Medical, provider of advanced cardiovascular specialty catheters used in the...
TVA Medical Receives CE Mark for Next-Generation EverlinQ 4 EndoAVF System
News | Vascular Access| October 04, 2017
TVA Medical Inc. announced that its everlinQ 4 endoAVF System has received CE Mark in the European Union. The...
Reflow Medical's Wingman Crossing Catheter Receives FDA Clearance for Coronary Indication
News | Catheters| October 02, 2017
October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S.
Overlay Init